2025
SJR Q3
JCR Q4 · 1,5
OA
6 matched articles
SCIE
Journal detail
Biomedical Research (Japan)
- Publisher
- Biomedical Research Foundation
- Country
- Japan · Asiatic Region
- Type
- journal
- ISSN
-
038861071880313X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,387
- Quartile Q3
- H-Index 46
- Cites/doc 1,45
- Docs (3y) 72
- Cites (3y) 100
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,5
- 5Y JIF 1,6
- JCI 0,34
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry, Genetics and Molecular Biology (miscellaneous) Q3
- Medicine (miscellaneous) Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,387 | 1,5 | 1,6 | 0,34 | Q4 | 46 |
| 2024 | Q3 | Q4 | 0,404 | 1,3 | 1,5 | 0,32 | Q4 | 44 |
| 2023 | Q3 | Q4 | 0,375 | 1,3 | 1,7 | 0,28 | Q4 | 44 |
| 2022 | Q3 | Q4 | 0,365 | 1,2 | 1,8 | 0,25 | Q4 | 44 |
| 2021 | Q3 | Q3 | 0,335 | 3 | 4,3 | 0,31 | Q4 | 44 |
| 2020 | Q2 | Q4 | 0,532 | 1,2 | 1,6 | 0,43 | Q3 | 44 |
| 2019 | Q2 | Q4 | 0,591 | 1,4 | 1,3 | 0,52 | Q3 | 44 |
| 2018 | — | Q4 | — | 1,2 | 1,3 | 0,53 | Q3 | — |
| 2017 | Q2 | Q4 | 0,565 | 1,3 | 1,3 | 0,46 | Q3 | 44 |
| 2016 | Q2 | Q4 | 0,549 | 0,9 | 1,1 | — | — | 44 |
| 2015 | Q2 | Q4 | 0,522 | 1 | 1,1 | — | — | 44 |
| 2014 | Q2 | Q4 | 0,612 | 1,1 | 1,3 | — | — | 44 |
| 2013 | Q2 | Q4 | 0,558 | 1,1 | 1,3 | — | — | 44 |
| 2012 | Q2 | Q3 | 0,581 | 1,3 | 1,3 | — | — | 44 |
| 2011 | Q2 | Q3 | 0,578 | 1,2 | 1,4 | — | — | 44 |
| 2010 | Q2 | Q3 | 0,465 | 1,3 | 1,2 | — | — | 44 |
| 2009 | — | Q4 | — | 1,1 | 1,2 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 0,7 | — | — | — |
| 2007 | — | Q4 | — | 1 | 0,5 | — | — | — |
| 2006 | — | Q4 | — | 0,5 | — | — | — | — |
| 2004 | — | Q4 | — | 0,3 | — | — | — | — |
| 2003 | — | Q4 | — | 0,4 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q4 | — | 0,4 | — | — | — | — |
| 2000 | — | Q4 | — | 0,6 | — | — | — | — |
| 1999 | — | Q3 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 146/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 153/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 148/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 120/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q4 | 100/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 127/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 119/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 117/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 111/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 109/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 107/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 101/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 96/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 86/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 78/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 72/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 70/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 64/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 66/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/76 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 66/71 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 67/72 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/74 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 67/75 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 58/74 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 53/76 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 45/72 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 36/61 |